Metastasis is one of the major causes of death in colorectal cancer (CRC) patients. MiR-222 has been reported to be an oncogene in many types of cancer. However, its role in CRC cell invasion and migration as well as CRC downstream signaling pathways remains largely unknown. Our study found that miR-222 overexpression promotes the migration and invasion of CRC cell lines, and miR-222 interference results, as expected, in inhibition of migration and invasion. Bioinformatic analysis and dual luciferase reporter assay showed that mammalian STE20-like protein kinase 3 (MST3) may be the target gene of miR-222. Down-expression of MST3 in CRC cell lines enhanced their migration and invasion, but overexpression of MST3 could attenuate miR-222 overexpression in the promotion of migration and invasion in colorectal cell lines. HCT116 cell lines overexpressing miR-222 were transplanted into nude mice resulting in more lung metastases than in the control group. Further study found that MST3 may play a role in paxillin phosphorylation to reduce adhesion, or increase the invadopodia. These findings demonstrate that miR-222 modulates MST3 and therefore plays a critical role in regulating CRC cell migration and invasion. Thus, miR-222 may be a novel therapeutic target for CRC.
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Colorectal cancer (CRC) is the third most common malignancy in males and the second in females worldwide, with 1.2 million new patients being diagnosed each year [1, 2] . Metastasis is one of the major causes of death in CRC patients. Approximately 50-60% of CRC patients develop distant metastases after surgery and their 5-year survival rate is less than 12% [3] .
Therefore, a better understanding of the mechanisms that govern CRC metastasis will provide information on novel biomarkers for oncologists to screen in patients with high metastatic risk and provide patients with customized treatments. Additionally, it may suggest new therapeutic targets to reduce the incidence of distant metastasis.
Many signaling pathways, such as transforming growth factor-b/Smad, Wnt/b-catenin and mitogen-activated protein kinase, have been reported to regulate CRC metastasis [4] . In addition to signaling pathways, the roles of non-coding RNAs in CRC metastasis have also been intensively investigated. MiRNAs, a class of small, noncoding RNAs, can bind to the 3 0 -untranslated region (UTR) of target genes and regulate gene expression at the post-transcriptional level [5] . Recently, a number of groups have demonstrated abnormal miRNA expression in CRC tissues compared to normal tissues [6] [7] [8] [9] [10] [11] [12] , and significant progress has been made in elucidating the specific roles of miRNAs in the initiation, progression and metastasis of CRC. For example, as a highly expressed onco-miRNA in many cancers, including CRC, high miR-21 expression is correlated with chemotherapy insensitivity and poor prognosis [10] . MiR-143 and miR-145 can exert tumor-suppressive functions and have low expression in CRC [13] . MiR-543 inhibited CRC cell metastasis in vitro and in vivo by targeting KRAS, MTA1 and HMGA2 [14] . MiR-34a-5p suppresses metastasis and its expression predicts recurrence in patients with stage II/ III CRC [15] . Pro-metastatic effects of miRNAs in CRC have also been reported. For example, miR-625-3p exerts its oncogenic functions in CRC metastasis by regulating the suppressor of cancer cell invasion/E-cadherin/matrix metalloproteinase-9 pathways [16] .
Increased levels of miR-222 have been reported in plasma as well as in tumor tissues from CRC patients [17, 18] . MiR-222 can promote CRC cell proliferation by promoting a positive feedback loop to increase RelA and signal transducer and activator of transcription 3 expression levels [19] . Stinson et al. [20] reported that miR-221/ 222 promoted breast cancer migration and invasion by down-regulating TRPS1 expression, which suggested that TRPS1 is a tumor suppressor gene in breast cancer. However, Hong et al. [21] reported that TRPS1 was an oncogene in CRC. Therefore, the mechanism by which miR-222 affects the migration and metastasis of CRC still needs further research. In this study, we found that overexpression of miR-222 significantly promoted migration and invasion of CRC cells through MST3, whose expression is inversely correlated with miR-222 in CRC specimens and predicted disease-free survival. Our study suggests that miR-222 may be a critical determinant of CRC metastasis.
Materials and methods

Clinical specimens
Twenty-one CRC tissue samples were obtained from patients with CRC treated between 2014 and 2015 and were stored liquid nitrogen-frozen.
The study conformed the guidelines set by the Declaration of Helsinki. The patients were enrolled after obtaining their informed consent according to procedures approved by the Ethics Committee at Peking Union Medical College hospital.
Tumor cell culture
The human SW480, HCT8, HCT116 and Lovo CRC cell lines were purchased from Cell Resource Center, IBMS, CAMS/PUMC (Beijing, China). SW480 was established from a primary colon adenocarcinoma in a 50-year-old male. HCT8 was derived from an ileocecal colorectal adenocarcinoma in a 67-year-old male. HCT116 was derived from a colorectal carcinoma in a male adult. Lovo was derived from a colorectal adenocarcinoma in a 56-year-old male patient. All of the cell lines were maintained in Dulbecco's modified Eagle's medium (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal calf serum (Thermo Fisher Scientific) in a humidified 5% CO 2 atmosphere at 37°C.
miRNA and siRNA transfection miRNA and siRNA transfections were performed as previously described [22] . The synthetic miR-222 mimic (forward, from GenePharma, Inc., Shanghai, China, and have been previously described [23] . The si-MST3 sequence is 5 0 -GGA GAA GAG CCA GGC GTG C-3 0 [24] .
RNA reverse transcription and qRT-PCR
Total RNA was extracted using the TRIzol total RNA isolation reagent (Thermo Fisher Scientific) and purified with the Column DNA Erasol kit (Tiangen, Beijing, China) according to the manufacturers' instructions. In the reverse transcription step, cDNAs were synthesized using a highcapacity cDNA reverse transcription Kit (Thermo Fisher Scientific) and levels were assessed with qRT-PCR using SYBR Green I (TaKaRa, Dalian, China). The gene expression levels were normalized to the endogenous reference gene GAPDH. The experiments were performed in triplicate. Reverse transcription of miRNAs was performed with a miScript Reverse Transcription Kit (Hilden, Duesseldorf, Germany). The expression of mature miRNAs was determined using miRNA-specific qRT-PCR (TaKaRa). The primers are listed in Tables S1 and S2 .
Western blot analysis
This protocol was performed as previously described [25] . After washing twice with PBS, the cells were lysed in ice- 
Dual luciferase reporter gene construct and dual luciferase reporter assay
To identify potential miR-222 targets, we first used TargetScan and PicTar web to predict targets. Based on known miRNAs, mRNAs that may be targeted are predicted, and genes associated with tumor invasion and invasion were selected based on the function of the mRNA. Fragments from the MST3, PTEN, TIMP2, RECK and PLXNC1 3 0 -UTRs contained the predicted binding site for hsa-miR-222, and flanking sequences on each side were synthesized with a short extension containing cleavage sites for XhoI (5 0 -end) and NotI (3 0 -end) (Table S3 ); a second fragment containing a mutated binding site sequence was also synthesized. The two constructs were termed wild-type (WT) and mutant (MT). The fragments were cloned into the psiCHECK TM -2 vector (Promega Corp., Madison, WI, USA). Ten nanograms of WT, MT or control vector and 200 nM miR-222 mimic were transfected into 293T cells using Lipofectamine 2000 (Thermo Fisher Scientific) according to the manufacturer's instructions. The cells were harvested 24 h after transfection and assayed for Renilla and firefly luciferase activities using the Dual Luciferase Reporter Assay System (Promega Corp.). This protocol was performed as previously described [23, 26] .
MST3 overexpression
A plasmid vector of the MST3 pReceiver-M68 expression clone was purchased from FulenGene (EX-T8396-M68, Guangzhou, China). MST3 overexpression or control plasmid was transfected into CRC cell lines with Lipofectamine 3000 (Thermo Fisher Scientific). The transfection efficacy was determined by RT-PCR at 24 h and by western blot at 48 h.
Immunofluorescence experiments
Cells were fixed at room temperature in 4% paraformaldehyde for 10 min, permeabilized with cold acetone for 10 min, and stained with MST3 antibody (1 : 100, Cell Signaling Technology) at room temperature for 1 h. After washing with PBS, a second antibody was added (Alexa FluorÒ 488-conjugated anti-rabbit IgG, 1 : 200; Abcam, Cambridge, MA, USA); after washing, cells were incubated with 0.1 lgÁmL À1 Hoechst 33342 (Thermo Fisher Scientific), before being observed under a confocal microscope (Olympus, Tokyo, Japan).
Invadopodia assay
To detect invadopodia, cells were fixed at room temperature in 4% paraformaldehyde for 10 min and permeabilized with cold acetone for 10 min. Next,cells were stained with rhodamine-conjugated phalloidin (1 : 200; Thermo Fisher Scientific) and a Alexa FluorÒ 488-conjugated anti-cortactin antibody (1 : 200; Abcam) at room temperature for 1 h; after washing, cells were incubated with 0.1 lgÁmL
À1
Hoechst 33342, before being observed under a confocal microscope (Olympus).
Adhesion assay
According to the reported method of adhesion assay, 100 lgÁmL À1 fibronectin (FN) was added to 96-well culture plates at 100 lL per well [27] . Plates were incubated overnight at 4°C. After washing once with PBS, it was blocked with 1% BSA for 2 h at 37°C. After washing twice with RPMI 1640 medium, the coated cell culture plates were used for an adhesion assay; the BSA control group was not coated with FN, and treated with 1% BSA alone. Cells at 0.5 9 10 6 cells per mL were added to the FN-coated cell culture plate and 1% BSA blocked culture plate at 100 lL per well, and the plates incubated in a CO 2 incubator for 60 min at 37°C. Non-adherent cells were aspirated, plates were washed twice with PBS, and attached cells were stained with crystal violet (dissolved in glacial acetic acid), and detect with a plate reader at 570 nm. The number of adherent cells (D) was the experimental group D minus the BSA control group.
Lentiviral transduction particle preparation and transduction
This protocol was performed as previously described [25] . MiR-222 and a negative control expression cassette were first constructed in the pGLV10/U6/RFP/Puro vector (GenePharma). The inserted hsa-mir-222 sequence was 5 0 -GCTGCTGGAAGGTGTAGGTACCCTCAATGGCTCA GTAGCCAGTGTAGATCCTGTCTTTCGTAATCAGCA GCTACATCTGGCTACTGGGTCTCTGATGGCATCTT CTAGCT-3 0 . Lentiviral transduction particles were prepared and provided by GenePharma, Inc. Successfully transduced HCT116 cells were selected in culture medium containing puromycin (2 lgÁmL À1 ) 24 h after transduction.
The transduction efficiency was evaluated by detecting red fluorescent protein expression under a fluorescence microscope, and the miR-222 expression level was determined by qRT-PCR 2 weeks after selection.
Evaluation of metastasis regulation by miR-222 in mice
This protocol was performed as previously described [25] . Six-to eight-week-old male nude mice (BALB/c-nu) were purchased from the Experimental Animal Institute of the Chinese Academy of Medical Sciences (Beijing, China). The mice were bred and maintained under specifically pathogen-free conditions in individually ventilated (highefficiency particle-arresting filtered air) sterile microisolator cages (Techniplast, Milan, Italy). All of the animal handling and experimental procedures were approved by the Animal Care and Use Committee of the Chinese Academy of Medical Sciences. HCT116-miR-222 and HCT116-NC cells were prepared (5 9 10 6 cells in 200 lL PBS) and inoculated subcutaneously at the right forelimb armpit. Histological evaluation of tumor metastasis in the liver, lung and colorectum was performed on these two groups of mice (HCT116-miR-222 and HCT116-NC) every 2 weeks.
Immunohistochemistry and assessment
Immunohistochemical staining was performed on 4 mm sections from 38 paraffin-embedded specimens. The slides were baked at 65°C for 30 min, deparaffinized with xylene and rehydrated with ethanol. For antigen retrieval, the slides were microwave-treated and boiled in a 0.01 M citrate buffer (pH 6.0) for 10 min at 95°C. Endogenous peroxidase activity was blocked with 3% hydrogen peroxide for 10 min. The slides were incubated with anti-MST3 antibody (1/100; cat number 3723S; Cell Signaling Technology) overnight at 4°C in a humidified chamber. The tissue sections were treated with biotinylated anti-rabbit secondary antibody (Thermo Fisher Scientific), followed by further incubation with a streptavidin-horseradish peroxidase complex (Thermo Fisher Scientific). The antigen-antibody complexes were visualized using 3,3 0 -diaminobenzidine, counterstained with 10% Mayer's hematoxylin, dehydrated, and mounted in Crystal Mount. The degree of immunostaining on the formalin-fixed, paraffin-embedded sections was reviewed and scored independently by two observers based on the proportion of positively stained cells and the intensity of the staining. If > 10% of the tumor cells or normal colon epithelial cells were stained, we defined the specimen as positive.
Statistical analysis
Comparisons between groups were analyzed using Student's t-test (two-sided). Differences with P values of less than 0.05 are considered significant. Correlations between miR-222 and MST3 expression were determined with Pearson's assay and correlation with the bivariate Kendall's tau-b assay.
Results
miR-222 promotes CRC cell line migration and invasion in vitro
To investigate the significance of miR-222 in CRC, we first detected the expression of miR-222 in the human SW480, HCT8, HCT116 and Lovo CRC cell lines by RT-PCR. The DC T value was used to represent the expression level of miR-222 in each cell type. A higher ΔC T indicated lower miR-222 levels. As shown in Fig. S1 , miR-222 levels were higher in HCT116 and LOVO cells compared to SW480 and HCT8 cells. The human SW480, HCT8, HCT116 and Lovo CRC cell lines were then transfected with the miR-222 mimic, mimic control, miR-222 inhibitor and inhibitor control. The transfection efficiency is shown in Fig. S2 . The four cell lines were next analyzed for their invasion and migration capacities via transwell chamber assays. Compared with the control group, CRC cells transfected with miR-222 mimic had significantly higher invasion and migration capacities, while CRC cells transfected with the miR-222 inhibitor had dramatically lower invasion and migration capacities (Fig. 1) . These results suggested that miR-222 promoted CRC invasion and migration. MiR-222 directly decreases MST3 expression by interacting with its 3 0 -UTR miRNAs exert their effects by regulating target genes at the post-transcriptional level. To identify potential targets of miR-222, we first used TargetScan and PicTar web to predict targets. Five genes, MST3, PTEN, PLXNC1, RECK and TIMP2, were selected based on the literature and their roles in migration and invasion. We next searched the literature for reported functions of these genes. The dual luciferase reporter assays revealed that the luciferase activities of MST3-WTtransfected cells significantly decreased upon miR-222 overexpression. However, the inhibitory effects were abolished when the putative miR-222 seed binding regions in the MST3 3 0 -UTR were mutated (Fig. 2B,  C) . MiR-222 overexpression had no effect on the luciferase activities of the other four genes (PTEN, PLXNC1, RECK and TIMP2; Fig. S3 ). Figure 2A demonstrates the conserved and poorly conserved miR-222 binding sites in the MST3 3 0 -UTR. MiR-222 overexpression or down-regulation had no effects on MST3 mRNA levels (Fig. 2D) . MiR-222 overexpression in SW480 cells and HCT116 cells reduced MST3 protein levels, while miR-222 inhibition increased MST3 levels determined by western blot analysis (Fig. 2E,F) . Similar results were obtained in HCT8 and Lovo cells (Fig. S4) . Immunofluorescence staining of MST3 with miR-222 overexpression or inhibition in four CRC cell lines showed the same trend of MST3 expression (Fig. S5 ). These data demonstrate that MST3 is a direct target of miR-222.
Down-regulation of MST3 increases invasion and migration in CRC cell lines
The expression of MST3 in CRC cell lines was detected by western blot (Fig. S1B) . To investigate whether MST3 down-regulation could have effects on CRC cell migration and invasion, the expression of MST3 in HCT116 and HCT8 cells was suppressed by small interfering RNAs (siRNAs) (Fig. S6) . The cell migration and invasion assay results showed that Lovo and HCT8 cell migration and invasion were significantly increased compared to the control group after MST3 down-regulation (Fig. 3) . We then evaluated the effect of MST3 overexpression. SW480 and HCT116 cells were transfected with MST3 overexpression or control plasmid vectors. The transfection efficiency is shown in Fig. S7 . MST3 overexpression significantly reduced migration and invasion in SW480 and HCT116 cells (Fig. 4) . To further confirm the miR-222 effect was mediated by MST3, we performed an RNA interference rescue assay. Overexpression of MST3 could rescue the promoting effects of miR-222 overexpression on CRC migration and invasion (Fig. 4) . MST3 has been reported to regulate metastasis in breast cancer via paxillin, whose phosphorylation inhibits cell migration and invasion [24, 28] . Here, we found increased paxillin phosphorylation in HCT8 cells transfected with the MST3 overexpression plasmid, and this effect was rescued when miR-222 was also overexpressed (Fig. 5) . These data suggest that miR-222 affects CRC migration and invasion by targeting MST3, which subsequently regulates paxillin phosphorylation. 
miR-222 and MST3 influence invadopodia formation and cell adhesion
In order to further study the mechanism by which miR-222 and MST3 regulate the migration and invasion of CRC cell lines, we investigated whether miR-222 and MST3 affect the formation of invadopodia. After miR-222 overexpression and MST3 interference, we found that invadopodia of HCT116 cells and Lovo cells were increased, and after miR-222 interference, invadopodia were decreased ( Figs 6A and S8 ).
In the previous study, we found that MST3 affects paxillin phosphorylation, whereas the main function of paxillin is focal adhesion. Therefore, we further investigated the effect of miR-222 and MST3 on cell adhesion. The adhesion assay found that with miR-222 overexpression and MST3 interference, CRC cell line adhesion was decreased, while with miR-222 interference, CRC cell line adhesion was enhanced (Fig. 6B,C) .
miR-222 promotes metastasis in mice
To further characterize the effects of miR-222 in the CRC lines in vivo, we constructed HCT116 cells that stably overexpressed miR-222 (HCT116-miR-222) and the respective control cells (HCT116-NC) via lentiviral vector transfection. These cells were inoculated in the subcutaneous right forelimb armpit of nude mice. Mice from the two groups were sacrificed every 2 weeks to detect any developments of liver, lung or colorectal metastases. Until 6 weeks after inoculation, no metastases were detected in either group. At 8 weeks, lung metastatic masses were detected in the HCT116-miR-222 groups (4/5). In contrast, no metastases were detected after 8 weeks in the HCT116-NC groups (0/5) (Fig. S9) . No obvious liver or colorectal metastases were observed in either group.
Correlation between MST3 and miR-222 expression in CRC patients
The expression of MST3 and miR-222 was detected by immunohistochemistry and RT-PCR, respectively. The results showed that miR-222 expression was inversely correlated to MST3 expression; these data were statistically significant (P = 0.034, Table S4 ). The 21 patients' results are shown in Table S5 .
Discussion miR-222 has been reported to be overexpressed in many tumors and negatively correlated with prognosis, such as in non-small cell lung cancer [29] , gastric cancer [30] and bladder cancers [31] . It can promote oncogenic processes such as cell proliferation, invasion and metastases by repressing a series of targets. For example, miR-222 up-regulation can enhance proliferation by down-regulating its target P27 in lung cancer [32] and hepatocellular cancer [33] . In oral squamous cell carcinoma, miR-222 targeted the expression of p53 upregulated modulator of apoptosis and affected cell growth, invasiveness and apoptosis [34] .
In CRC, Liu et al. [19] found that human CRC tissues had higher miR-222 levels than non-tumor colon tissues and that miR-222 acted in a positive feedback loop to increase RelA and signal transducer and activator of transcription 3 expression levels. However, the role of miR-222 in CRC cell invasion and migration as well as the underlying molecular mechanisms There were four groups: the mimic control and overexpression control group, mimic control and MST3 overexpression group, miR-222 mimic and overexpression control group, and miR-222 mimic and MST3 overexpression group. Data represent the mean AE SD of four independent experiments. Comparisons between groups were analyzed using t-tests (two-sided). Differences with P values of less than 0.05 are considered significant. *P < 0.01. Scale bar: 100 lm. remains largely unknown. In this study, we found that miR-222 overexpression significantly promoted CRC cell migration and invasion in vitro and in vivo. To understand the mechanism of miR-222 actions in CRC, we predicted the potential target genes of miR-222 via TargetScan and PicTar web. Five genes, MST3, PTEN, PLXNC1, RECK and TIMP2, were selected for further evaluation based on the prediction. Through dual luciferase reporter assays, we confirmed the direct targets of miR-222 to specific sequences located in the MST3 3 0 -UTR. MST3 encodes a serine/ threonine protein kinase that functions upstream of mitogen-activated protein kinase signaling [35] . MST3 is closely related to tumor initiation, proliferation and metastasis. In breast cancer, it is controversial whether MST3 is an oncogene or a tumor suppressor gene. Lu et al. [24] found that MST3 was a tumor suppressor gene and that its downregulation resulted in enhanced MCF7 migration. In contrast, Cho et al. [36] demonstrated that MST3 was an oncogene that could promote proliferation and tumorigenicity in MDA-MB-231 cells. MST3 could regulate the mode of cancer cell migration by acting as the downstream molecule of the striatin-interacting phosphatase and kinase complex [37] . MiR-222 directly targets the metastasis-related protein MST3 [24, 37] , which can regulate paxillin phosphorylation [24] . Paxillin is an intracellular adaptor protein that plays a key role in cytoskeletal organization. It can connect integrins to focal adhesion kinase and affect the assembly and disassembly of focal adhesions [38] . We examined changes in the adhesion capacity of CRC cell lines after miR-222 interference and overexpression as well as MST3 interference, and the results were as expected. Paxillin phosphorylation can inhibit cell migration and invasion [24, 28] . Here, we found that MST3 could negatively regulate CRC cell invasion and migration. MST3 down-regulation promoted whereas MST3 up-regulation inhibited CRC cell migration and invasion. As a downstream target of MST3, we focused on paxillin, whose phosphorylation was increased by MST3. In addition, we also studied the effects of miR-222 overexpression, interference and MST3 interference on invadopodia formation. We found that both miR-222 overexpression and MST3 interference increased invadopodia formation in CRC cell lines. Therefore, miR-222 and MST3 may regulate migration and invasion through the regulation of invadopodia formation. The mechanism needs further study. To our knowledge, this is the first study to report that MST3 is a miR-222 target gene and that miR-222 can regulate CRC cell invasion and migration via MST3.
Furthermore, we also validated the in vitro results in clinical CRC patient tissues. MiR-222 expression was inversely correlated with MST3 levels in CRC tissues.
In conclusion, high miR-222 expression levels correlated with CRC migration and invasion. Our study showed for the first time that miR-222 enhances CRC cell migration and invasion by down-regulating MST3. The differential expression of MST3 between tumor and matched pericarcinous tissues may be useful for predicting prognosis in CRC patients. Comparisons between groups were analyzed using ttests (two-sided). Differences with P values of less than 0.05 are considered significant. Fig. S3 . The luciferase activity after transfection of the indicated 3 0 -UTR-or mutant 3 0 -UTR-driven reporter constructs for PTEN, PLXNC1, RECK and TIMP2. Comparisons between groups were analyzed using ttests (two-sided). Differences with P values of less than 0.05 are considered significant. Fig. S4 . Western blot assay of MST3 protein levels in HCT8 and Lovo cells treated with miR-222 mimics, mimics control, miR-222 inhibitor and inhibitor control (n = 3). .  Table S1 . The primers (mRNA) for real time PCR .  Table S2 . The primers (miRNA) for real time PCR. Table S3 . The sequence of target gene wild-type and mutation of 3 0 -UTR. Table S4 . The correlation between miR-222 and MST3 in 21 fresh liquid nitrogen-frozen CRC cancer tissue from 2014 to 2015 .  Table S5 . The expression miR-222 and MST3 of colorectal cancer patients (2014) (2015) . 
